By Mark De Belder2011-12-28T00:03:00
A new treatment available to combat valvular heart disease could be an opportunity to improve the care provided to those who would previously have been too ill for open heart surgery - and cut mortality rates in patients with the disease. Dr Mark De Belder explains.
With a HSJ subscription you’ll unlock:
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud